Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ingo Schmidt-Wolf"'
Autor:
Maximilian Günther, Leopold Hentschel, Markus Schuler, Theresa Müller, Katharina Schütte, Yon-Dschun Ko, Ingo Schmidt-Wolf, Ulrich Jaehde
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background To include the patient perspective in the assessment of adverse events in oncology, a patient-reported outcomes (PRO) version of the Common Terminology Criteria for Adverse Events (CTCAE) was developed by the US National Cancer In
Externí odkaz:
https://doaj.org/article/2bc95743b3ef4a1a8a84868e4f45a15f
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0307831 (2024)
BackgroundTransitions of care after cancer treatment pose a major challenge for patient safety as adverse events and unplanned healthcare utilization occur frequently. At this point, patient and family engagement (PFE) is particularly valuable since
Externí odkaz:
https://doaj.org/article/d3c82e7e8d3a455a96830bcb738f3fe7
Publikováno v:
Head & Face Medicine, Vol 16, Iss 1, Pp 1-12 (2020)
Abstract Background Periodontal ligament (PDL) cells initiate local immune responses, similar to microglia regulating primary host defense mechanisms in neuroinflammatory events of the central nervous system. As these two cell types manifest similari
Externí odkaz:
https://doaj.org/article/4a4d8d0e6e3a46e4a848a066fde80dec
Autor:
Maximilian Günther, Leopold Hentschel, Markus Schuler, Theresa Müller, Katharina Schütte, Yon-Dschun Ko, Ingo Schmidt-Wolf, Ulrich Jaehde
Background To include the patient perspective in the assessment of adverse events (AE) in oncology, a patient-reported outcomes (PRO) version of the Common Terminology Criteria for Adverse Events (CTCAE) was developed by the NCI, the so called PRO-CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b36bec6572cb89ecb9a8fade2c1b954c
https://doi.org/10.21203/rs.3.rs-2824306/v1
https://doi.org/10.21203/rs.3.rs-2824306/v1
Autor:
Maximilian Merz, Anna Jauch, Thomas Hielscher, Elias K. Mai, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc S. Raab, Hans Salwender, Igor W. Blau, Hans-Walter Lindemann, Ingo Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja Weisel, Hartmut Goldschmidt, Jens Hillengass
Publikováno v:
Haematologica, Vol 102, Iss 8 (2017)
To investigate cytogenetic evolution after upfront autologous stem cell transplantation for newly diagnosed myeloma we retrospectively analyzed fluorescence in situ hybridization results of 128 patients with paired bone marrow samples from the time o
Externí odkaz:
https://doaj.org/article/6f20db778e2c42bbab8181edbef9bfa2
Autor:
Young Kim, Ingo Schmidt-Wolf
Publikováno v:
Springer Reference Medizin ISBN: 9783662467640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4524df8badc74adcfbbd555b65cc988
https://doi.org/10.1007/978-3-662-46764-0_371-1
https://doi.org/10.1007/978-3-662-46764-0_371-1
Autor:
Annekristin, Hausen, Diana, Henschel, Regina, Heuser, Marie, Harnischmacher, Christiane, Kloeß, Alexander, Pröbstl, Ingo, Schmidt-Wolf, Christian P, Strassburg, Jörg C, Kalff, Martin, von Websky
Publikováno v:
Zentralblatt fur Chirurgie. 146(3)
Malnutrition in hospitalised patients is an important and underestimated problem, with a negative impact on outcome and survival - not only in surgical patients. There is a discrepancy between optimal treatment as defined in relevant guidelines on cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4bdbaed0de7865b3b5378decd8b731aa
https://pubmed.ncbi.nlm.nih.gov/34154010
https://pubmed.ncbi.nlm.nih.gov/34154010
Autor:
Nkem Purity C. Emekwue, Ommega Internationals, Ingo Schmidt-Wolf, Hans Weiher Ingo G.H. Schmidt-Wolf
Publikováno v:
International Journal of Hematology and Therapy. 4:16-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8d7cc55cb40d0b570558110044c633
https://doi.org/10.15436/2381-1404.18.1666
https://doi.org/10.15436/2381-1404.18.1666
Autor:
Michael Nowak, Mohammed S Arredouani, Adrian Tun-Kyi, Ingo Schmidt-Wolf, Martin G Sanda, Steven P Balk, Mark A Exley
Publikováno v:
PLoS ONE, Vol 5, Iss 6, p e11311 (2010)
Numerical and functional defects of invariant natural killer T cells (iNKT) have been documented in human and mouse cancers, resulting in a defect in IFN production in several malignancies. iNKT cells recognize glycolipids presented on CD1d molecules
Externí odkaz:
https://doaj.org/article/93aa2fff4c9f40ef9fa68fef02e3c611
Autor:
Henk M. Lokhorst, Ingo Schmidt-Wolf, Pieter Sonneveld, Bronno van der Holt, Hans Martin, Rene Barge, Uta Bertsch, Jana Schlenzka, Gerard M.J. Bos, Sandra Croockewit, Sonja Zweegman, Iris Breitkreutz, Peter Joosten, Christof Scheid, Marinus van Marwijk-Kooy, Hans-Juergen Salwender, Marinus H.J. van Oers, Ron Schaafsma, Ralph Naumann, Harm Sinnige, Igor Blau, Michel Delforge, Okke de Weerdt, Pierre Wijermans, Shulamiet Wittebol, Ulrich Duersen, Edo Vellenga, Hartmut Goldschmidt
Publikováno v:
Haematologica, Vol 93, Iss 1 (2008)
In the prospective phase 3 HOVON-50/GMMG-HD3 trial, patients randomized to TAD (thalidomide, doxorubicin, dexamethasone) had a significantly higher response rate (at least PR) after induction compared with patients randomized to VAD (vincristine, adr
Externí odkaz:
https://doaj.org/article/cde5267fd127455282cfd518e36718c1